Notice of Third Quarter 2016 Trading Update

19 July 2016

UDG Healthcare plc

Notice of Third Quarter 2016 Trading Update

UDG Healthcare plc ("the Company"), a leading international healthcare services provider, will issue a trading update for the third quarter to 30 June 2016 at 7.00am (BST) on Thursday, 4 August 2016.

The Company will also host a conference call for investors and analysts at 9.00am (BST) on Thursday, 4 August 2016 to discuss the statement. The dial-in details are as follows:

A playback facility will be available for seven days on +44 (0) 20 8196 1998. The access code for the replay will be 6580690#.

For further information, please contact:

Keith Byrne

Head of Investor Relations & Strategy

UDG Healthcare plc

Tel: +353-1-4689000

Lisa Kavanagh / Jack Hickey

Powerscourt

Tel: +44-207-250-1446

Email: [email protected]

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international provider of services to the healthcare industry, employing over 7,000 employees at operations across 19 countries including the US, UK, Ireland and Germany.

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services.

Ashfield Commercial & Medical Services is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three broad areas of activity: contract sales outsourcing, healthcare communications and clinical solutions. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance (drug safety), regulatory and event management services to over 300 healthcare companies in 18 countries.

Sharp Packaging Services is a global leader in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Supply Chain Services consists of Aquilant, a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information please go to: www.udghealthcare.com